Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

  1. Jové, M.
  2. Pradas, I.
  3. Naudí, A.
  4. Rovira-Llopis, S.
  5. Bañuls, C.
  6. Rocha, M.
  7. Portero-Otin, M.
  8. Hernández-Mijares, A.
  9. Victor, V.M.
  10. Pamplona, R.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2018

Volumen: 9

Número: 4

Pages: 4522-4536

Type: Article

DOI: 10.18632/ONCOTARGET.23393 GOOGLE SCHOLAR lock_openAccès ouvert editor